血管内超声在冠状动脉疾病中应用的中国专家共识(2018)

2018-05-20 中国心血管相关专家小组(统称) 中华心血管病杂志, 2018,46(5) : 344-351.

血管内超声(intravascular ultrasound,IVUS)通过导管技术将微型超声探头送入血管腔内,显示血管横截面图像,从而提供在体血管腔内影像。IVUS能够精确测定管腔、血管直径以及判断病变严重程度及性质,在提高对冠状动脉病变的认识和指导介入治疗方面起了非常重要的作用。本共识专家组依据国内外IVUS临床研究结果,结合国内临床应用经验和体会,以实用为主旨,拟定了本共识,以期规范操作,并

中文标题:

血管内超声在冠状动脉疾病中应用的中国专家共识(2018)

发布日期:

2018-05-20

简要介绍:

血管内超声(intravascular ultrasound,IVUS)通过导管技术将微型超声探头送入血管腔内,显示血管横截面图像,从而提供在体血管腔内影像。IVUS能够精确测定管腔、血管直径以及判断病变严重程度及性质,在提高对冠状动脉病变的认识和指导介入治疗方面起了非常重要的作用。本共识专家组依据国内外IVUS临床研究结果,结合国内临床应用经验和体会,以实用为主旨,拟定了本共识,以期规范操作,并提高临床医生腔内影像学的运用和解读水平。 

拓展指南:冠状动脉相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=血管内超声在冠状动脉疾病中应用的中国专家共识(2018))] GetToolGuiderByIdResponse(projectId=1, id=349951c001595803, title=血管内超声在冠状动脉疾病中应用的中国专家共识(2018), enTitle=, guiderFrom=中华心血管病杂志, 2018,46(5) : 344-351., authorId=null, author=, summary=血管内超声(intravascular ultrasound,IVUS)通过导管技术将微型超声探头送入血管腔内,显示血管横截面图像,从而提供在体血管腔内影像。IVUS能够精确测定管腔、血管直径以及判断病变严重程度及性质,在提高对冠状动脉病变的认识和指导介入治疗方面起了非常重要的作用。本共识专家组依据国内外IVUS临床研究结果,结合国内临床应用经验和体会,以实用为主旨,拟定了本共识,以期规范操作,并, cover=, journalId=null, articlesId=null, associationId=306, associationName=中国心血管相关专家小组(统称), associationIntro=本制定者非特指某个专家小组,为统称。, copyright=0, guiderPublishedTime=Sun May 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>血管内超声(intravascular ultrasound,IVUS)通过导管技术将微型超声探头送入血管腔内,显示血管横截面图像,从而提供在体血管腔内影像。IVUS能够精确测定管腔、血管直径以及判断病变严重程度及性质,在提高对冠状动脉病变的认识和指导介入治疗方面起了非常重要的作用。本共识专家组依据国内外IVUS临床研究结果,结合国内临床应用经验和体会,以实用为主旨,拟定了本共识,以期规范操作,并提高临床医生腔内影像学的运用和解读水平。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>冠状动脉</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=13c171c001591ad7" title="急性冠状动脉综合征特殊人群抗血小板治疗中国专家建议" target=_blank>急性冠状动脉综合征特殊人群抗血小板治疗中国专家建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=cbb361c001591160" title="中国冠状动脉慢性完全闭塞病变介入治疗推荐路径" target=_blank>中国冠状动脉慢性完全闭塞病变介入治疗推荐路径</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7470e1c00158a1e7" title="2018 SCAI专家共识:经皮冠状动脉介入治疗后住院停留时间" target=_blank>2018 SCAI专家共识:经皮冠状动脉介入治疗后住院停留时间</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=88d121c001560335" title="2018 AHA科学声明:自发性冠状动脉夹层" target=_blank>2018 AHA科学声明:自发性冠状动脉夹层</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1e13c1c0015602d5" title="2018 ESC意见书:自发性冠状动脉夹层" target=_blank>2018 ESC意见书:自发性冠状动脉夹层</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89" target=_blank>有关冠状动脉更多指南</a></ul>, tagList=[TagDto(tagId=3968, tagName=血管内超声), TagDto(tagId=1993, tagName=冠状动脉疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11630, appHits=477, showAppHits=7, pcHits=8370, showPcHits=4533, likes=143, shares=17, comments=61, approvalStatus=1, publishedTime=Fri May 25 22:35:24 CST 2018, publishedTimeString=2018-05-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri May 25 22:35:24 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:53:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=血管内超声在冠状动脉疾病中应用的中国专家共识(2018))])
血管内超声在冠状动脉疾病中应用的中国专家共识(2018)
下载请点击:
评论区 (60)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1181182, encodeId=26f5118118207, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5cb2267138, createdName=12198262m01暂无昵称, createdTime=Thu Jan 06 09:30:50 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057186, encodeId=bef7105e1861f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:10:38 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057179, encodeId=1dec105e179af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:09:57 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003867, encodeId=12d9100386e43, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30255560323, createdName=ms8000001091767266, createdTime=Fri Jul 30 14:38:27 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321675, encodeId=72a93216e5cf, content= 学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Jun 05 13:15:07 CST 2018, time=2018-06-05, status=1, ipAttribution=)]
    2022-01-06 12198262m01暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1181182, encodeId=26f5118118207, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5cb2267138, createdName=12198262m01暂无昵称, createdTime=Thu Jan 06 09:30:50 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057186, encodeId=bef7105e1861f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:10:38 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057179, encodeId=1dec105e179af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:09:57 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003867, encodeId=12d9100386e43, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30255560323, createdName=ms8000001091767266, createdTime=Fri Jul 30 14:38:27 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321675, encodeId=72a93216e5cf, content= 学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Jun 05 13:15:07 CST 2018, time=2018-06-05, status=1, ipAttribution=)]
    2021-10-03 H8888888

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1181182, encodeId=26f5118118207, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5cb2267138, createdName=12198262m01暂无昵称, createdTime=Thu Jan 06 09:30:50 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057186, encodeId=bef7105e1861f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:10:38 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057179, encodeId=1dec105e179af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:09:57 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003867, encodeId=12d9100386e43, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30255560323, createdName=ms8000001091767266, createdTime=Fri Jul 30 14:38:27 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321675, encodeId=72a93216e5cf, content= 学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Jun 05 13:15:07 CST 2018, time=2018-06-05, status=1, ipAttribution=)]
    2021-10-03 H8888888

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1181182, encodeId=26f5118118207, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5cb2267138, createdName=12198262m01暂无昵称, createdTime=Thu Jan 06 09:30:50 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057186, encodeId=bef7105e1861f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:10:38 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057179, encodeId=1dec105e179af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:09:57 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003867, encodeId=12d9100386e43, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30255560323, createdName=ms8000001091767266, createdTime=Fri Jul 30 14:38:27 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321675, encodeId=72a93216e5cf, content= 学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Jun 05 13:15:07 CST 2018, time=2018-06-05, status=1, ipAttribution=)]
    2021-07-30 ms8000001091767266

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1181182, encodeId=26f5118118207, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5cb2267138, createdName=12198262m01暂无昵称, createdTime=Thu Jan 06 09:30:50 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057186, encodeId=bef7105e1861f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:10:38 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057179, encodeId=1dec105e179af, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:09:57 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003867, encodeId=12d9100386e43, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30255560323, createdName=ms8000001091767266, createdTime=Fri Jul 30 14:38:27 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321675, encodeId=72a93216e5cf, content= 学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Jun 05 13:15:07 CST 2018, time=2018-06-05, status=1, ipAttribution=)]
    2018-06-05 xiaotao112411

    学习学习学习

    0